NOXOPHARM LIMITED — Director's Dealing 2017

Nov 28, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Noxopharm Limited ABN 50 608 966 123

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Peter Marks
Date of last notice	10 August 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change		28 November 2017
No. of securities held prior to change		DIRECTN/AINDIRECTLampam Pty Ltd <Peter Marks Super A/C>1. 240,000 ordinary shares2. 260,000 ordinary shares (escrow to9/8/2018)3. 200,000 unlisted options $0.30, expiry28/2/2021 (escrow to 9/8/2018)4. 0 unlisted options $1.0158, expiry27/11/20205. 0 unlisted options $1.2189, expiry27/11/2020

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class		4. unlistedoptions$1.0158,expiry27/11/20205. unlistedoptions$1.2189,expiry27/11/2020
Number acquired		4. 250,000unlistedoptions$1.0158,expiry 27/11/20205. 250,000unlistedoptions$1.2189,expiry27/11/2020
Number disposed		N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		4. N/A – Director option grant5. N/A – Director option grant
No. of securities held after change		DIRECTN/AINDIRECTLampam Pty Ltd <Peter Marks Super A/C>1. 240,000 ordinary shares2. 260,000 ordinary shares (escrow to9/8/2018)3. 200,000 unlisted options $0.30, expiry28/2/2021 (escrow to 9/8/2018)4. 250,000unlistedoptions$1.0158,expiry 27/11/20205. 250,000unlistedoptions$1.2189,expiry 27/11/2020
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back		4. Director option grant as approved byshareholders on 27 November 20175. Director option grant as approved byshareholders on 27 November 2017

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities)

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3